Nothing Special   »   [go: up one dir, main page]

PT1297006E - Regulacao de protease serinica semelhante a prostasina humana - Google Patents

Regulacao de protease serinica semelhante a prostasina humana

Info

Publication number
PT1297006E
PT1297006E PT01967085T PT01967085T PT1297006E PT 1297006 E PT1297006 E PT 1297006E PT 01967085 T PT01967085 T PT 01967085T PT 01967085 T PT01967085 T PT 01967085T PT 1297006 E PT1297006 E PT 1297006E
Authority
PT
Portugal
Prior art keywords
human prostasin
regulation
serenial
protease similar
prostasin
Prior art date
Application number
PT01967085T
Other languages
English (en)
Inventor
Xiao Yonghong
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of PT1297006E publication Critical patent/PT1297006E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT01967085T 2000-06-23 2001-06-22 Regulacao de protease serinica semelhante a prostasina humana PT1297006E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21347400P 2000-06-23 2000-06-23
US27761201P 2001-03-22 2001-03-22

Publications (1)

Publication Number Publication Date
PT1297006E true PT1297006E (pt) 2006-05-31

Family

ID=26908122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01967085T PT1297006E (pt) 2000-06-23 2001-06-22 Regulacao de protease serinica semelhante a prostasina humana

Country Status (9)

Country Link
US (2) US7049420B2 (pt)
EP (1) EP1297006B1 (pt)
AT (1) ATE317399T1 (pt)
AU (1) AU2001287555A1 (pt)
DE (1) DE60117155T2 (pt)
DK (1) DK1297006T3 (pt)
ES (1) ES2258099T3 (pt)
PT (1) PT1297006E (pt)
WO (1) WO2001098466A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485957B1 (en) 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
CA2590751A1 (en) * 2004-12-13 2006-06-22 Roy Rabindranauth Sooknanan Polynucleotides and polypeptide sequences involved in the process of bone remodeling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485957B1 (en) * 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
EP1227833A1 (en) * 1999-10-07 2002-08-07 Human Genome Sciences, Inc. Plasminogen-like polynucleotides, polypeptides, and antibodies
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
EP1292684A2 (en) * 2000-06-16 2003-03-19 Incyte Genomics, Inc. Proteases
WO2001098467A2 (en) * 2000-06-23 2001-12-27 Bayer Aktiengesellschaft Regulation of human prostasin-like serine protease

Also Published As

Publication number Publication date
WO2001098466A3 (en) 2002-08-15
WO2001098466A2 (en) 2001-12-27
EP1297006B1 (en) 2006-02-08
US20040141962A1 (en) 2004-07-22
AU2001287555A1 (en) 2002-01-02
ATE317399T1 (de) 2006-02-15
US7538205B2 (en) 2009-05-26
US7049420B2 (en) 2006-05-23
ES2258099T3 (es) 2006-08-16
DE60117155D1 (de) 2006-04-20
DE60117155T2 (de) 2006-09-28
DK1297006T3 (da) 2006-05-22
EP1297006A2 (en) 2003-04-02
US20060154293A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
ATE394491T1 (de) Regulierung einer humanen transmembran- serinprotease
Jabłońska-Trypuć et al. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Shapiro et al. Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate: DIFFERENTIAL PROCESSING AND STABILIZATION OF THE CARBOXYL-TERMINAL DOMAIN BY TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP)(∗)
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
Chen et al. Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts.
DE59608385D1 (de) Verwendung von mutierter subtilisin-protease in kosmetischen produkten
Han et al. Tumor necrosis factor-α-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase
NO20025376D0 (no) Nye multicykliske forbindelser og anvendelser derav
Zucker et al. Extraction of type‐IV collagenase/gelatinase from plasma membranes of human cancer cells
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DK1326963T3 (da) Mikroorganismer, som er gjort ikke-patogene
Kobayashi et al. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes
DK1071704T3 (da) Nye matrix metalloproteinasehæmmere og nedregulatorer
PT1297006E (pt) Regulacao de protease serinica semelhante a prostasina humana
WO2001096378A3 (en) Human epithin-like serine protease
WO2002008392A3 (en) Regulation of human matriptase-like serine protease
Oliveira et al. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel PI metalloproteinase from Bothrops jararaca venom
WO2001098340A3 (en) Regulation of human mast cell protease 6-like enzyme
ATE390137T1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
BR9811748A (pt) Genes microbianos para ß-glucuronidasessecretadas, produtos de gene e seus usos
PT996709E (pt) Inibidores de enzimas celuloliticas, xilanoliticas e betaglucanoliticas
WO2001072973A3 (en) Regulation of human heparanase-like enzyme
WO2001098467A3 (en) Regulation of human prostasin-like serine protease
WO2001085959A3 (en) Regulation of human lysostaphin-like protease